nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—AOX1—Methotrexate—multiple sclerosis	0.167	0.237	CbGbCtD
Raloxifene—CYP19A1—Betamethasone—multiple sclerosis	0.167	0.236	CbGbCtD
Raloxifene—CYP19A1—Dexamethasone—multiple sclerosis	0.0969	0.137	CbGbCtD
Raloxifene—CYP3A4—Fingolimod—multiple sclerosis	0.0504	0.0714	CbGbCtD
Raloxifene—CYP2B6—Dexamethasone—multiple sclerosis	0.04	0.0566	CbGbCtD
Raloxifene—CYP3A4—Methylprednisolone—multiple sclerosis	0.0325	0.046	CbGbCtD
Raloxifene—CYP2C8—Dexamethasone—multiple sclerosis	0.0303	0.0429	CbGbCtD
Raloxifene—CYP3A4—Triamcinolone—multiple sclerosis	0.0246	0.0348	CbGbCtD
Raloxifene—CYP3A4—Mitoxantrone—multiple sclerosis	0.0237	0.0335	CbGbCtD
Raloxifene—CYP3A4—Betamethasone—multiple sclerosis	0.0211	0.0299	CbGbCtD
Raloxifene—CYP3A4—Prednisolone—multiple sclerosis	0.0208	0.0295	CbGbCtD
Raloxifene—CYP3A4—Prednisone—multiple sclerosis	0.0197	0.0279	CbGbCtD
Raloxifene—CYP3A4—Dexamethasone—multiple sclerosis	0.0123	0.0174	CbGbCtD
Raloxifene—EBP—Azacitidine—Cladribine—multiple sclerosis	0.00263	1	CbGdCrCtD
Raloxifene—Diabetes mellitus—Prednisone—multiple sclerosis	0.000655	0.00334	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.000651	0.00332	CcSEcCtD
Raloxifene—Breast disorder—Methylprednisolone—multiple sclerosis	0.00065	0.00332	CcSEcCtD
Raloxifene—Insomnia—Cladribine—multiple sclerosis	0.000646	0.0033	CcSEcCtD
Raloxifene—Migraine—Betamethasone—multiple sclerosis	0.000644	0.00329	CcSEcCtD
Raloxifene—Migraine—Dexamethasone—multiple sclerosis	0.000644	0.00329	CcSEcCtD
Raloxifene—Cystitis noninfective—Methotrexate—multiple sclerosis	0.000641	0.00327	CcSEcCtD
Raloxifene—Cystitis—Methotrexate—multiple sclerosis	0.000633	0.00323	CcSEcCtD
Raloxifene—Influenza—Triamcinolone—multiple sclerosis	0.000623	0.00318	CcSEcCtD
Raloxifene—Vaginal infection—Methotrexate—multiple sclerosis	0.000619	0.00316	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000617	0.00315	CcSEcCtD
Raloxifene—Weight increased—Prednisolone—multiple sclerosis	0.000617	0.00315	CcSEcCtD
Raloxifene—Pain—Cladribine—multiple sclerosis	0.000611	0.00312	CcSEcCtD
Raloxifene—Myalgia—Azathioprine—multiple sclerosis	0.000606	0.00309	CcSEcCtD
Raloxifene—Arthralgia—Azathioprine—multiple sclerosis	0.000606	0.00309	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000602	0.00307	CcSEcCtD
Raloxifene—Bronchitis—Triamcinolone—multiple sclerosis	0.000599	0.00306	CcSEcCtD
Raloxifene—Bladder pain—Methotrexate—multiple sclerosis	0.000593	0.00303	CcSEcCtD
Raloxifene—Conjunctivitis—Prednisolone—multiple sclerosis	0.000587	0.003	CcSEcCtD
Raloxifene—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000584	0.00298	CcSEcCtD
Raloxifene—Infection—Azathioprine—multiple sclerosis	0.000577	0.00294	CcSEcCtD
Raloxifene—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000569	0.0029	CcSEcCtD
Raloxifene—Weight increased—Triamcinolone—multiple sclerosis	0.000567	0.00289	CcSEcCtD
Raloxifene—Weight increased—Methylprednisolone—multiple sclerosis	0.000566	0.00289	CcSEcCtD
Raloxifene—Abdominal pain—Cladribine—multiple sclerosis	0.000565	0.00288	CcSEcCtD
Raloxifene—Body temperature increased—Cladribine—multiple sclerosis	0.000565	0.00288	CcSEcCtD
Raloxifene—Skin disorder—Azathioprine—multiple sclerosis	0.000564	0.00288	CcSEcCtD
Raloxifene—Diabetes mellitus—Methotrexate—multiple sclerosis	0.000547	0.00279	CcSEcCtD
Raloxifene—Conjunctivitis—Triamcinolone—multiple sclerosis	0.00054	0.00276	CcSEcCtD
Raloxifene—Sweating—Methylprednisolone—multiple sclerosis	0.000532	0.00271	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000529	0.0027	CcSEcCtD
Raloxifene—Weight increased—Dexamethasone—multiple sclerosis	0.000515	0.00263	CcSEcCtD
Raloxifene—Weight increased—Betamethasone—multiple sclerosis	0.000515	0.00263	CcSEcCtD
Raloxifene—Cough—Mitoxantrone—multiple sclerosis	0.000502	0.00256	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000502	0.00256	CcSEcCtD
Raloxifene—Rhinitis—Triamcinolone—multiple sclerosis	0.0005	0.00255	CcSEcCtD
Raloxifene—Rhinitis—Methylprednisolone—multiple sclerosis	0.000499	0.00255	CcSEcCtD
Raloxifene—Pharyngitis—Triamcinolone—multiple sclerosis	0.000495	0.00253	CcSEcCtD
Raloxifene—Conjunctivitis—Dexamethasone—multiple sclerosis	0.00049	0.0025	CcSEcCtD
Raloxifene—Conjunctivitis—Betamethasone—multiple sclerosis	0.00049	0.0025	CcSEcCtD
Raloxifene—Chest pain—Mitoxantrone—multiple sclerosis	0.00049	0.0025	CcSEcCtD
Raloxifene—Arthralgia—Mitoxantrone—multiple sclerosis	0.00049	0.0025	CcSEcCtD
Raloxifene—Myalgia—Mitoxantrone—multiple sclerosis	0.00049	0.0025	CcSEcCtD
Raloxifene—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000489	0.0025	CcSEcCtD
Raloxifene—Diarrhoea—Cladribine—multiple sclerosis	0.000489	0.00249	CcSEcCtD
Raloxifene—Cerebrovascular accident—Methotrexate—multiple sclerosis	0.000486	0.00248	CcSEcCtD
Raloxifene—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000475	0.00242	CcSEcCtD
Raloxifene—Dizziness—Cladribine—multiple sclerosis	0.000473	0.00241	CcSEcCtD
Raloxifene—Infection—Mitoxantrone—multiple sclerosis	0.000467	0.00238	CcSEcCtD
Raloxifene—Shock—Mitoxantrone—multiple sclerosis	0.000462	0.00236	CcSEcCtD
Raloxifene—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000462	0.00236	CcSEcCtD
Raloxifene—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00046	0.00235	CcSEcCtD
Raloxifene—Body temperature increased—Azathioprine—multiple sclerosis	0.000459	0.00234	CcSEcCtD
Raloxifene—Abdominal pain—Azathioprine—multiple sclerosis	0.000459	0.00234	CcSEcCtD
Raloxifene—Skin disorder—Mitoxantrone—multiple sclerosis	0.000456	0.00233	CcSEcCtD
Raloxifene—Vomiting—Cladribine—multiple sclerosis	0.000454	0.00232	CcSEcCtD
Raloxifene—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000454	0.00232	CcSEcCtD
Raloxifene—Angiopathy—Methylprednisolone—multiple sclerosis	0.000452	0.0023	CcSEcCtD
Raloxifene—Rash—Cladribine—multiple sclerosis	0.000451	0.0023	CcSEcCtD
Raloxifene—Dermatitis—Cladribine—multiple sclerosis	0.00045	0.0023	CcSEcCtD
Raloxifene—Weight increased—Prednisone—multiple sclerosis	0.000448	0.00229	CcSEcCtD
Raloxifene—Headache—Cladribine—multiple sclerosis	0.000448	0.00228	CcSEcCtD
Raloxifene—Depression—Prednisone—multiple sclerosis	0.000438	0.00223	CcSEcCtD
Raloxifene—Breast disorder—Methotrexate—multiple sclerosis	0.00043	0.0022	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000428	0.00218	CcSEcCtD
Raloxifene—Nausea—Cladribine—multiple sclerosis	0.000424	0.00217	CcSEcCtD
Raloxifene—Vertigo—Prednisolone—multiple sclerosis	0.000424	0.00216	CcSEcCtD
Raloxifene—Syncope—Prednisolone—multiple sclerosis	0.000423	0.00216	CcSEcCtD
Raloxifene—Loss of consciousness—Prednisolone—multiple sclerosis	0.000415	0.00212	CcSEcCtD
Raloxifene—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000413	0.00211	CcSEcCtD
Raloxifene—Angiopathy—Dexamethasone—multiple sclerosis	0.000411	0.00209	CcSEcCtD
Raloxifene—Angiopathy—Betamethasone—multiple sclerosis	0.000411	0.00209	CcSEcCtD
Raloxifene—Pain—Mitoxantrone—multiple sclerosis	0.000402	0.00205	CcSEcCtD
Raloxifene—Diarrhoea—Azathioprine—multiple sclerosis	0.000398	0.00203	CcSEcCtD
Raloxifene—Vertigo—Triamcinolone—multiple sclerosis	0.00039	0.00199	CcSEcCtD
Raloxifene—Syncope—Triamcinolone—multiple sclerosis	0.000389	0.00199	CcSEcCtD
Raloxifene—Vertigo—Methylprednisolone—multiple sclerosis	0.000389	0.00199	CcSEcCtD
Raloxifene—Syncope—Methylprednisolone—multiple sclerosis	0.000389	0.00198	CcSEcCtD
Raloxifene—Connective tissue disorder—Prednisone—multiple sclerosis	0.000387	0.00198	CcSEcCtD
Raloxifene—Dizziness—Azathioprine—multiple sclerosis	0.000384	0.00196	CcSEcCtD
Raloxifene—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000384	0.00196	CcSEcCtD
Raloxifene—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000382	0.00195	CcSEcCtD
Raloxifene—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000381	0.00194	CcSEcCtD
Raloxifene—Shock—Prednisolone—multiple sclerosis	0.000379	0.00193	CcSEcCtD
Raloxifene—Cough—Triamcinolone—multiple sclerosis	0.000379	0.00193	CcSEcCtD
Raloxifene—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000373	0.0019	CcSEcCtD
Raloxifene—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000371	0.00189	CcSEcCtD
Raloxifene—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000371	0.00189	CcSEcCtD
Raloxifene—Myalgia—Triamcinolone—multiple sclerosis	0.00037	0.00189	CcSEcCtD
Raloxifene—Vomiting—Azathioprine—multiple sclerosis	0.000369	0.00188	CcSEcCtD
Raloxifene—Pneumonia—Methotrexate—multiple sclerosis	0.000369	0.00188	CcSEcCtD
Raloxifene—Myalgia—Methylprednisolone—multiple sclerosis	0.000369	0.00188	CcSEcCtD
Raloxifene—Arthralgia—Methylprednisolone—multiple sclerosis	0.000369	0.00188	CcSEcCtD
Raloxifene—Rash—Azathioprine—multiple sclerosis	0.000366	0.00187	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000366	0.00187	CcSEcCtD
Raloxifene—Dermatitis—Azathioprine—multiple sclerosis	0.000366	0.00187	CcSEcCtD
Raloxifene—Depression—Methotrexate—multiple sclerosis	0.000366	0.00187	CcSEcCtD
Raloxifene—Flushing—Prednisone—multiple sclerosis	0.000366	0.00187	CcSEcCtD
Raloxifene—Headache—Azathioprine—multiple sclerosis	0.000364	0.00186	CcSEcCtD
Raloxifene—Angiopathy—Prednisone—multiple sclerosis	0.000358	0.00182	CcSEcCtD
Raloxifene—Conjunctivitis—Methotrexate—multiple sclerosis	0.000357	0.00182	CcSEcCtD
Raloxifene—Vertigo—Dexamethasone—multiple sclerosis	0.000354	0.00181	CcSEcCtD
Raloxifene—Vertigo—Betamethasone—multiple sclerosis	0.000354	0.00181	CcSEcCtD
Raloxifene—Syncope—Betamethasone—multiple sclerosis	0.000353	0.0018	CcSEcCtD
Raloxifene—Syncope—Dexamethasone—multiple sclerosis	0.000353	0.0018	CcSEcCtD
Raloxifene—Infection—Triamcinolone—multiple sclerosis	0.000352	0.0018	CcSEcCtD
Raloxifene—Sweating—Methotrexate—multiple sclerosis	0.000352	0.00179	CcSEcCtD
Raloxifene—Infection—Methylprednisolone—multiple sclerosis	0.000351	0.00179	CcSEcCtD
Raloxifene—Shock—Triamcinolone—multiple sclerosis	0.000349	0.00178	CcSEcCtD
Raloxifene—Insomnia—Prednisolone—multiple sclerosis	0.000349	0.00178	CcSEcCtD
Raloxifene—Shock—Methylprednisolone—multiple sclerosis	0.000348	0.00177	CcSEcCtD
Raloxifene—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000347	0.00177	CcSEcCtD
Raloxifene—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000346	0.00177	CcSEcCtD
Raloxifene—Loss of consciousness—Betamethasone—multiple sclerosis	0.000346	0.00177	CcSEcCtD
Raloxifene—Nausea—Azathioprine—multiple sclerosis	0.000345	0.00176	CcSEcCtD
Raloxifene—Skin disorder—Methylprednisolone—multiple sclerosis	0.000343	0.00175	CcSEcCtD
Raloxifene—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000343	0.00175	CcSEcCtD
Raloxifene—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000342	0.00174	CcSEcCtD
Raloxifene—Myalgia—Dexamethasone—multiple sclerosis	0.000335	0.00171	CcSEcCtD
Raloxifene—Myalgia—Betamethasone—multiple sclerosis	0.000335	0.00171	CcSEcCtD
Raloxifene—Pain—Prednisolone—multiple sclerosis	0.00033	0.00168	CcSEcCtD
Raloxifene—Pharyngitis—Methotrexate—multiple sclerosis	0.000327	0.00167	CcSEcCtD
Raloxifene—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000325	0.00166	CcSEcCtD
Raloxifene—Urethral disorder—Methotrexate—multiple sclerosis	0.000323	0.00165	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000323	0.00165	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000322	0.00164	CcSEcCtD
Raloxifene—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000321	0.00164	CcSEcCtD
Raloxifene—Insomnia—Triamcinolone—multiple sclerosis	0.000321	0.00164	CcSEcCtD
Raloxifene—Insomnia—Methylprednisolone—multiple sclerosis	0.00032	0.00163	CcSEcCtD
Raloxifene—Infection—Dexamethasone—multiple sclerosis	0.000319	0.00163	CcSEcCtD
Raloxifene—Infection—Betamethasone—multiple sclerosis	0.000319	0.00163	CcSEcCtD
Raloxifene—Shock—Betamethasone—multiple sclerosis	0.000316	0.00161	CcSEcCtD
Raloxifene—Shock—Dexamethasone—multiple sclerosis	0.000316	0.00161	CcSEcCtD
Raloxifene—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000315	0.00161	CcSEcCtD
Raloxifene—Nervous system disorder—Betamethasone—multiple sclerosis	0.000315	0.00161	CcSEcCtD
Raloxifene—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000315	0.00161	CcSEcCtD
Raloxifene—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000315	0.00161	CcSEcCtD
Raloxifene—Dyspepsia—Triamcinolone—multiple sclerosis	0.000312	0.00159	CcSEcCtD
Raloxifene—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000311	0.00159	CcSEcCtD
Raloxifene—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000311	0.00159	CcSEcCtD
Raloxifene—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000311	0.00159	CcSEcCtD
Raloxifene—Vertigo—Prednisone—multiple sclerosis	0.000308	0.00157	CcSEcCtD
Raloxifene—Syncope—Prednisone—multiple sclerosis	0.000308	0.00157	CcSEcCtD
Raloxifene—Cardiac disorder—Methotrexate—multiple sclerosis	0.000306	0.00156	CcSEcCtD
Raloxifene—Pain—Triamcinolone—multiple sclerosis	0.000303	0.00155	CcSEcCtD
Raloxifene—Loss of consciousness—Prednisone—multiple sclerosis	0.000302	0.00154	CcSEcCtD
Raloxifene—Angiopathy—Methotrexate—multiple sclerosis	0.000299	0.00152	CcSEcCtD
Raloxifene—Vomiting—Mitoxantrone—multiple sclerosis	0.000299	0.00152	CcSEcCtD
Raloxifene—Rash—Mitoxantrone—multiple sclerosis	0.000296	0.00151	CcSEcCtD
Raloxifene—Dermatitis—Mitoxantrone—multiple sclerosis	0.000296	0.00151	CcSEcCtD
Raloxifene—Headache—Mitoxantrone—multiple sclerosis	0.000294	0.0015	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000293	0.00149	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000293	0.00149	CcSEcCtD
Raloxifene—Arthralgia—Prednisone—multiple sclerosis	0.000292	0.00149	CcSEcCtD
Raloxifene—Myalgia—Prednisone—multiple sclerosis	0.000292	0.00149	CcSEcCtD
Raloxifene—Insomnia—Dexamethasone—multiple sclerosis	0.000291	0.00148	CcSEcCtD
Raloxifene—Insomnia—Betamethasone—multiple sclerosis	0.000291	0.00148	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00029	0.00148	CcSEcCtD
Raloxifene—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000289	0.00148	CcSEcCtD
Raloxifene—Dyspepsia—Dexamethasone—multiple sclerosis	0.000283	0.00144	CcSEcCtD
Raloxifene—Dyspepsia—Betamethasone—multiple sclerosis	0.000283	0.00144	CcSEcCtD
Raloxifene—Body temperature increased—Triamcinolone—multiple sclerosis	0.00028	0.00143	CcSEcCtD
Raloxifene—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00028	0.00143	CcSEcCtD
Raloxifene—Nausea—Mitoxantrone—multiple sclerosis	0.000279	0.00142	CcSEcCtD
Raloxifene—Infection—Prednisone—multiple sclerosis	0.000278	0.00142	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000278	0.00142	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000278	0.00142	CcSEcCtD
Raloxifene—Shock—Prednisone—multiple sclerosis	0.000276	0.00141	CcSEcCtD
Raloxifene—Pain—Dexamethasone—multiple sclerosis	0.000275	0.0014	CcSEcCtD
Raloxifene—Pain—Betamethasone—multiple sclerosis	0.000275	0.0014	CcSEcCtD
Raloxifene—Nervous system disorder—Prednisone—multiple sclerosis	0.000275	0.0014	CcSEcCtD
Raloxifene—Skin disorder—Prednisone—multiple sclerosis	0.000272	0.00139	CcSEcCtD
Raloxifene—Hyperhidrosis—Prednisone—multiple sclerosis	0.000271	0.00138	CcSEcCtD
Raloxifene—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000263	0.00134	CcSEcCtD
Raloxifene—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000263	0.00134	CcSEcCtD
Raloxifene—Vertigo—Methotrexate—multiple sclerosis	0.000258	0.00131	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000255	0.0013	CcSEcCtD
Raloxifene—Dizziness—Prednisolone—multiple sclerosis	0.000255	0.0013	CcSEcCtD
Raloxifene—Abdominal pain—Betamethasone—multiple sclerosis	0.000254	0.0013	CcSEcCtD
Raloxifene—Body temperature increased—Betamethasone—multiple sclerosis	0.000254	0.0013	CcSEcCtD
Raloxifene—Abdominal pain—Dexamethasone—multiple sclerosis	0.000254	0.0013	CcSEcCtD
Raloxifene—Body temperature increased—Dexamethasone—multiple sclerosis	0.000254	0.0013	CcSEcCtD
Raloxifene—Insomnia—Prednisone—multiple sclerosis	0.000253	0.00129	CcSEcCtD
Raloxifene—Cough—Methotrexate—multiple sclerosis	0.00025	0.00128	CcSEcCtD
Raloxifene—Dyspepsia—Prednisone—multiple sclerosis	0.000247	0.00126	CcSEcCtD
Raloxifene—Chest pain—Methotrexate—multiple sclerosis	0.000244	0.00125	CcSEcCtD
Raloxifene—Myalgia—Methotrexate—multiple sclerosis	0.000244	0.00125	CcSEcCtD
Raloxifene—Arthralgia—Methotrexate—multiple sclerosis	0.000244	0.00125	CcSEcCtD
Raloxifene—Rash—Prednisolone—multiple sclerosis	0.000243	0.00124	CcSEcCtD
Raloxifene—Dermatitis—Prednisolone—multiple sclerosis	0.000243	0.00124	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000242	0.00124	CcSEcCtD
Raloxifene—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000242	0.00123	CcSEcCtD
Raloxifene—Headache—Prednisolone—multiple sclerosis	0.000241	0.00123	CcSEcCtD
Raloxifene—Dizziness—Triamcinolone—multiple sclerosis	0.000234	0.0012	CcSEcCtD
Raloxifene—Dizziness—Methylprednisolone—multiple sclerosis	0.000234	0.00119	CcSEcCtD
Raloxifene—Infection—Methotrexate—multiple sclerosis	0.000233	0.00119	CcSEcCtD
Raloxifene—Nervous system disorder—Methotrexate—multiple sclerosis	0.00023	0.00117	CcSEcCtD
Raloxifene—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000229	0.00117	CcSEcCtD
Raloxifene—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000229	0.00117	CcSEcCtD
Raloxifene—Nausea—Prednisolone—multiple sclerosis	0.000229	0.00117	CcSEcCtD
Raloxifene—Skin disorder—Methotrexate—multiple sclerosis	0.000227	0.00116	CcSEcCtD
Raloxifene—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000226	0.00115	CcSEcCtD
Raloxifene—Vomiting—Triamcinolone—multiple sclerosis	0.000225	0.00115	CcSEcCtD
Raloxifene—Vomiting—Methylprednisolone—multiple sclerosis	0.000225	0.00115	CcSEcCtD
Raloxifene—Rash—Triamcinolone—multiple sclerosis	0.000223	0.00114	CcSEcCtD
Raloxifene—Dermatitis—Triamcinolone—multiple sclerosis	0.000223	0.00114	CcSEcCtD
Raloxifene—Rash—Methylprednisolone—multiple sclerosis	0.000223	0.00114	CcSEcCtD
Raloxifene—Dermatitis—Methylprednisolone—multiple sclerosis	0.000223	0.00114	CcSEcCtD
Raloxifene—Headache—Triamcinolone—multiple sclerosis	0.000222	0.00113	CcSEcCtD
Raloxifene—Headache—Methylprednisolone—multiple sclerosis	0.000222	0.00113	CcSEcCtD
Raloxifene—Body temperature increased—Prednisone—multiple sclerosis	0.000221	0.00113	CcSEcCtD
Raloxifene—Abdominal pain—Prednisone—multiple sclerosis	0.000221	0.00113	CcSEcCtD
Raloxifene—Diarrhoea—Betamethasone—multiple sclerosis	0.00022	0.00112	CcSEcCtD
Raloxifene—Diarrhoea—Dexamethasone—multiple sclerosis	0.00022	0.00112	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000213	0.00109	CcSEcCtD
Raloxifene—Dizziness—Dexamethasone—multiple sclerosis	0.000213	0.00108	CcSEcCtD
Raloxifene—Dizziness—Betamethasone—multiple sclerosis	0.000213	0.00108	CcSEcCtD
Raloxifene—Insomnia—Methotrexate—multiple sclerosis	0.000212	0.00108	CcSEcCtD
Raloxifene—Nausea—Triamcinolone—multiple sclerosis	0.000211	0.00107	CcSEcCtD
Raloxifene—Nausea—Methylprednisolone—multiple sclerosis	0.00021	0.00107	CcSEcCtD
Raloxifene—Dyspepsia—Methotrexate—multiple sclerosis	0.000206	0.00105	CcSEcCtD
Raloxifene—Vomiting—Betamethasone—multiple sclerosis	0.000204	0.00104	CcSEcCtD
Raloxifene—Vomiting—Dexamethasone—multiple sclerosis	0.000204	0.00104	CcSEcCtD
Raloxifene—Rash—Betamethasone—multiple sclerosis	0.000203	0.00103	CcSEcCtD
Raloxifene—Rash—Dexamethasone—multiple sclerosis	0.000203	0.00103	CcSEcCtD
Raloxifene—Dermatitis—Dexamethasone—multiple sclerosis	0.000203	0.00103	CcSEcCtD
Raloxifene—Dermatitis—Betamethasone—multiple sclerosis	0.000203	0.00103	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000202	0.00103	CcSEcCtD
Raloxifene—Headache—Dexamethasone—multiple sclerosis	0.000201	0.00103	CcSEcCtD
Raloxifene—Headache—Betamethasone—multiple sclerosis	0.000201	0.00103	CcSEcCtD
Raloxifene—Pain—Methotrexate—multiple sclerosis	0.0002	0.00102	CcSEcCtD
Raloxifene—Diarrhoea—Prednisone—multiple sclerosis	0.000192	0.000977	CcSEcCtD
Raloxifene—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000191	0.000976	CcSEcCtD
Raloxifene—Nausea—Dexamethasone—multiple sclerosis	0.000191	0.000974	CcSEcCtD
Raloxifene—Nausea—Betamethasone—multiple sclerosis	0.000191	0.000974	CcSEcCtD
Raloxifene—Dizziness—Prednisone—multiple sclerosis	0.000185	0.000945	CcSEcCtD
Raloxifene—Abdominal pain—Methotrexate—multiple sclerosis	0.000185	0.000944	CcSEcCtD
Raloxifene—Body temperature increased—Methotrexate—multiple sclerosis	0.000185	0.000944	CcSEcCtD
Raloxifene—Vomiting—Prednisone—multiple sclerosis	0.000178	0.000908	CcSEcCtD
Raloxifene—Rash—Prednisone—multiple sclerosis	0.000177	0.000901	CcSEcCtD
Raloxifene—Dermatitis—Prednisone—multiple sclerosis	0.000176	0.0009	CcSEcCtD
Raloxifene—Headache—Prednisone—multiple sclerosis	0.000175	0.000895	CcSEcCtD
Raloxifene—Nausea—Prednisone—multiple sclerosis	0.000166	0.000849	CcSEcCtD
Raloxifene—Diarrhoea—Methotrexate—multiple sclerosis	0.00016	0.000817	CcSEcCtD
Raloxifene—Dizziness—Methotrexate—multiple sclerosis	0.000155	0.000789	CcSEcCtD
Raloxifene—Vomiting—Methotrexate—multiple sclerosis	0.000149	0.000759	CcSEcCtD
Raloxifene—Rash—Methotrexate—multiple sclerosis	0.000148	0.000753	CcSEcCtD
Raloxifene—Dermatitis—Methotrexate—multiple sclerosis	0.000147	0.000752	CcSEcCtD
Raloxifene—Headache—Methotrexate—multiple sclerosis	0.000147	0.000748	CcSEcCtD
Raloxifene—Nausea—Methotrexate—multiple sclerosis	0.000139	0.000709	CcSEcCtD
Raloxifene—ESR1—AP-1 transcription factor network—IL6—multiple sclerosis	8.83e-05	0.000927	CbGpPWpGaD
Raloxifene—AOX1—Disease—CD28—multiple sclerosis	8.83e-05	0.000927	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—CCL5—multiple sclerosis	8.72e-05	0.000915	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	8.4e-05	0.000882	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	8.4e-05	0.000882	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—ZFP36L1—multiple sclerosis	8.23e-05	0.000864	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.21e-05	0.000862	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TAGAP—multiple sclerosis	8.12e-05	0.000853	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	8.06e-05	0.000846	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—CCL5—multiple sclerosis	7.96e-05	0.000836	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	7.89e-05	0.000828	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—CCR5—multiple sclerosis	7.86e-05	0.000825	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LINGO1—multiple sclerosis	7.81e-05	0.000819	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—S1PR1—multiple sclerosis	7.78e-05	0.000817	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GPC5—multiple sclerosis	7.69e-05	0.000807	CbGpPWpGaD
Raloxifene—EBP—Metabolism—APOE—multiple sclerosis	7.68e-05	0.000806	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—SRM—multiple sclerosis	7.66e-05	0.000804	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—GPC5—multiple sclerosis	7.57e-05	0.000794	CbGpPWpGaD
Raloxifene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.49e-05	0.000786	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	7.36e-05	0.000773	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—PTGER4—multiple sclerosis	7.33e-05	0.00077	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	7.2e-05	0.000756	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—CCR5—multiple sclerosis	7.17e-05	0.000753	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—S1PR1—multiple sclerosis	7.1e-05	0.000745	CbGpPWpGaD
Raloxifene—CYP2B6—Biological oxidations—POMC—multiple sclerosis	7.1e-05	0.000745	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	7.09e-05	0.000745	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CXCR3—multiple sclerosis	7.08e-05	0.000743	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—BCHE—multiple sclerosis	7.07e-05	0.000743	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	6.94e-05	0.000728	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CCL3—multiple sclerosis	6.92e-05	0.000726	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—GPC5—multiple sclerosis	6.91e-05	0.000725	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CCR2—multiple sclerosis	6.89e-05	0.000723	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TAGAP—multiple sclerosis	6.77e-05	0.00071	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—PTGER4—multiple sclerosis	6.69e-05	0.000703	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PTGER4—multiple sclerosis	6.66e-05	0.000699	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RGS1—multiple sclerosis	6.61e-05	0.000694	CbGpPWpGaD
Raloxifene—EBP—Metabolism—POMC—multiple sclerosis	6.6e-05	0.000693	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—VDR—multiple sclerosis	6.58e-05	0.00069	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—SRM—multiple sclerosis	6.49e-05	0.000681	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CXCR3—multiple sclerosis	6.46e-05	0.000679	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CXCR3—multiple sclerosis	6.43e-05	0.000675	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—PABPC1—multiple sclerosis	6.38e-05	0.00067	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—RRM1—multiple sclerosis	6.37e-05	0.000669	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CNR1—multiple sclerosis	6.36e-05	0.000667	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	6.35e-05	0.000667	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CCL3—multiple sclerosis	6.31e-05	0.000663	CbGpPWpGaD
Raloxifene—AOX1—Disease—CD86—multiple sclerosis	6.3e-05	0.000661	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CCR2—multiple sclerosis	6.29e-05	0.00066	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—VDR—multiple sclerosis	6.28e-05	0.000659	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—GPR65—multiple sclerosis	6.27e-05	0.000658	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CCR2—multiple sclerosis	6.26e-05	0.000657	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	6.21e-05	0.000652	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—MAPK1—multiple sclerosis	6.18e-05	0.000649	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—POMC—multiple sclerosis	6.14e-05	0.000644	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PTGER4—multiple sclerosis	6.08e-05	0.000638	CbGpPWpGaD
Raloxifene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.07e-05	0.000638	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RGS1—multiple sclerosis	6.04e-05	0.000634	CbGpPWpGaD
Raloxifene—EBP—Metabolism—ALB—multiple sclerosis	6.02e-05	0.000631	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—POMC—multiple sclerosis	6.01e-05	0.000631	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—CCL2—multiple sclerosis	6.01e-05	0.000631	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—S1PR1—multiple sclerosis	5.92e-05	0.000621	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CXCR3—multiple sclerosis	5.87e-05	0.000616	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CNR1—multiple sclerosis	5.8e-05	0.000609	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CNR1—multiple sclerosis	5.77e-05	0.000606	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—RPL5—multiple sclerosis	5.75e-05	0.000604	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GPC5—multiple sclerosis	5.75e-05	0.000604	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CXCL13—multiple sclerosis	5.74e-05	0.000602	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCR1—multiple sclerosis	5.74e-05	0.000602	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CXCL10—multiple sclerosis	5.72e-05	0.000601	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—GPR65—multiple sclerosis	5.72e-05	0.000601	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CCR2—multiple sclerosis	5.71e-05	0.000599	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	5.62e-05	0.00059	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—POMC—multiple sclerosis	5.6e-05	0.000588	CbGpPWpGaD
Raloxifene—AOX1—Disease—CCR5—multiple sclerosis	5.59e-05	0.000586	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—CCL2—multiple sclerosis	5.48e-05	0.000576	CbGpPWpGaD
Raloxifene—AOX1—Disease—HLA-A—multiple sclerosis	5.44e-05	0.000571	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	5.4e-05	0.000567	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	5.4e-05	0.000567	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CNR1—multiple sclerosis	5.27e-05	0.000553	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	5.26e-05	0.000552	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	5.25e-05	0.000551	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CXCL13—multiple sclerosis	5.24e-05	0.00055	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCR1—multiple sclerosis	5.24e-05	0.00055	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CXCL10—multiple sclerosis	5.23e-05	0.000549	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CXCL10—multiple sclerosis	5.2e-05	0.000546	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—MYC—multiple sclerosis	5.18e-05	0.000544	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	5.15e-05	0.00054	CbGpPWpGaD
Raloxifene—AOX1—Disease—APOE—multiple sclerosis	5.08e-05	0.000533	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RGS1—multiple sclerosis	5.03e-05	0.000528	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.94e-05	0.000519	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GPC5—multiple sclerosis	4.94e-05	0.000518	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CCL5—multiple sclerosis	4.93e-05	0.000517	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.9e-05	0.000514	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GPR65—multiple sclerosis	4.77e-05	0.000501	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—IL6—multiple sclerosis	4.75e-05	0.000498	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CXCL10—multiple sclerosis	4.75e-05	0.000498	CbGpPWpGaD
Raloxifene—AOX1—Disease—CD80—multiple sclerosis	4.59e-05	0.000482	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	4.57e-05	0.00048	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	4.57e-05	0.00048	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—PGR—multiple sclerosis	4.53e-05	0.000476	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CCL5—multiple sclerosis	4.5e-05	0.000472	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CCL5—multiple sclerosis	4.47e-05	0.00047	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.47e-05	0.000469	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CCR5—multiple sclerosis	4.44e-05	0.000466	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—IL2RA—multiple sclerosis	4.38e-05	0.000459	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CXCL13—multiple sclerosis	4.36e-05	0.000458	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCR1—multiple sclerosis	4.36e-05	0.000458	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	4.32e-05	0.000453	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—APOE—multiple sclerosis	4.26e-05	0.000447	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.25e-05	0.000446	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GPC5—multiple sclerosis	4.18e-05	0.000439	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—RRM1—multiple sclerosis	4.09e-05	0.000429	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCL3—multiple sclerosis	4.09e-05	0.000429	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CCL5—multiple sclerosis	4.08e-05	0.000429	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CCR5—multiple sclerosis	4.05e-05	0.000425	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CCR5—multiple sclerosis	4.03e-05	0.000423	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—IL2RA—multiple sclerosis	3.99e-05	0.000419	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL2RA—multiple sclerosis	3.97e-05	0.000417	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PTGER4—multiple sclerosis	3.93e-05	0.000413	CbGpPWpGaD
Raloxifene—AOX1—Disease—TYK2—multiple sclerosis	3.88e-05	0.000407	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PGR—multiple sclerosis	3.87e-05	0.000407	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.87e-05	0.000406	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CXCR3—multiple sclerosis	3.8e-05	0.000399	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CD28—multiple sclerosis	3.76e-05	0.000395	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCL3—multiple sclerosis	3.73e-05	0.000392	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCR2—multiple sclerosis	3.7e-05	0.000388	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CCR5—multiple sclerosis	3.68e-05	0.000386	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—BCHE—multiple sclerosis	3.66e-05	0.000384	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—POMC—multiple sclerosis	3.66e-05	0.000384	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL2RA—multiple sclerosis	3.63e-05	0.000381	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PTGER4—multiple sclerosis	3.59e-05	0.000377	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PGR—multiple sclerosis	3.54e-05	0.000371	CbGpPWpGaD
Raloxifene—AOX1—Disease—CD4—multiple sclerosis	3.51e-05	0.000368	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SRM—multiple sclerosis	3.48e-05	0.000365	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—POMC—multiple sclerosis	3.47e-05	0.000364	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CXCR3—multiple sclerosis	3.47e-05	0.000364	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—RRM1—multiple sclerosis	3.46e-05	0.000364	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CD28—multiple sclerosis	3.44e-05	0.000361	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CNR1—multiple sclerosis	3.41e-05	0.000358	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCR2—multiple sclerosis	3.37e-05	0.000354	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—ALB—multiple sclerosis	3.33e-05	0.00035	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.23e-05	0.000339	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—POMC—multiple sclerosis	3.17e-05	0.000332	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—VDR—multiple sclerosis	3.17e-05	0.000332	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—POMC—multiple sclerosis	3.15e-05	0.000331	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CNR1—multiple sclerosis	3.11e-05	0.000327	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCL3—multiple sclerosis	3.11e-05	0.000326	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CCL2—multiple sclerosis	3.08e-05	0.000324	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CXCL10—multiple sclerosis	3.07e-05	0.000322	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PTGER4—multiple sclerosis	2.99e-05	0.000314	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PGR—multiple sclerosis	2.95e-05	0.000309	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CXCR3—multiple sclerosis	2.89e-05	0.000303	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—POMC—multiple sclerosis	2.88e-05	0.000302	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CD28—multiple sclerosis	2.86e-05	0.0003	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CCL2—multiple sclerosis	2.81e-05	0.000295	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCR2—multiple sclerosis	2.81e-05	0.000295	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CXCL10—multiple sclerosis	2.8e-05	0.000294	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—TYK2—multiple sclerosis	2.8e-05	0.000294	CbGpPWpGaD
Raloxifene—AOX1—Disease—STAT3—multiple sclerosis	2.72e-05	0.000285	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.69e-05	0.000282	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CD86—multiple sclerosis	2.69e-05	0.000282	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCL5—multiple sclerosis	2.64e-05	0.000277	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—MYC—multiple sclerosis	2.61e-05	0.000274	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CNR1—multiple sclerosis	2.59e-05	0.000272	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—IL2—multiple sclerosis	2.57e-05	0.000269	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—TYK2—multiple sclerosis	2.56e-05	0.000268	CbGpPWpGaD
Raloxifene—AOX1—Disease—MYC—multiple sclerosis	2.52e-05	0.000265	CbGpPWpGaD
Raloxifene—AOX1—Disease—TGFB1—multiple sclerosis	2.52e-05	0.000264	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—MYC—multiple sclerosis	2.5e-05	0.000262	CbGpPWpGaD
Raloxifene—AOX1—Disease—MAPK1—multiple sclerosis	2.47e-05	0.000259	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.45e-05	0.000257	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.45e-05	0.000257	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CD86—multiple sclerosis	2.45e-05	0.000257	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SPP1—multiple sclerosis	2.45e-05	0.000257	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCL5—multiple sclerosis	2.41e-05	0.000253	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCR5—multiple sclerosis	2.38e-05	0.00025	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.35e-05	0.000247	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL2RA—multiple sclerosis	2.35e-05	0.000246	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—IL2—multiple sclerosis	2.34e-05	0.000246	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CXCL10—multiple sclerosis	2.34e-05	0.000245	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL2—multiple sclerosis	2.33e-05	0.000245	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.31e-05	0.000242	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.24e-05	0.000235	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SPP1—multiple sclerosis	2.23e-05	0.000235	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—APOE—multiple sclerosis	2.2e-05	0.000231	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCR5—multiple sclerosis	2.17e-05	0.000228	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—APOE—multiple sclerosis	2.17e-05	0.000227	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL2RA—multiple sclerosis	2.14e-05	0.000225	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL2—multiple sclerosis	2.13e-05	0.000223	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.1e-05	0.000221	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CD86—multiple sclerosis	2.04e-05	0.000214	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCL5—multiple sclerosis	2.01e-05	0.000211	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.99e-05	0.000209	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—APOE—multiple sclerosis	1.98e-05	0.000208	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CD80—multiple sclerosis	1.96e-05	0.000206	CbGpPWpGaD
Raloxifene—AOX1—Disease—IL6—multiple sclerosis	1.9e-05	0.000199	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—POMC—multiple sclerosis	1.89e-05	0.000198	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SPP1—multiple sclerosis	1.86e-05	0.000195	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—POMC—multiple sclerosis	1.86e-05	0.000195	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.86e-05	0.000195	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCL2—multiple sclerosis	1.82e-05	0.000191	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCR5—multiple sclerosis	1.81e-05	0.00019	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CD80—multiple sclerosis	1.79e-05	0.000188	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL2RA—multiple sclerosis	1.78e-05	0.000187	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—MAPK1—multiple sclerosis	1.78e-05	0.000187	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ALB—multiple sclerosis	1.72e-05	0.000181	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—POMC—multiple sclerosis	1.7e-05	0.000178	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCL2—multiple sclerosis	1.66e-05	0.000175	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TYK2—multiple sclerosis	1.65e-05	0.000174	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—APOE—multiple sclerosis	1.65e-05	0.000173	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—MAPK1—multiple sclerosis	1.63e-05	0.000171	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	1.51e-05	0.000158	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CD80—multiple sclerosis	1.49e-05	0.000156	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—POMC—multiple sclerosis	1.42e-05	0.000149	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—APOE—multiple sclerosis	1.41e-05	0.000148	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCL2—multiple sclerosis	1.38e-05	0.000145	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL2—multiple sclerosis	1.38e-05	0.000144	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL6—multiple sclerosis	1.37e-05	0.000144	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MMP9—multiple sclerosis	1.3e-05	0.000137	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—MYC—multiple sclerosis	1.26e-05	0.000132	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TYK2—multiple sclerosis	1.26e-05	0.000132	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL2—multiple sclerosis	1.26e-05	0.000132	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	1.25e-05	0.000131	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—POMC—multiple sclerosis	1.21e-05	0.000127	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—APOE—multiple sclerosis	1.2e-05	0.000126	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	1.19e-05	0.000125	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—STAT3—multiple sclerosis	1.16e-05	0.000122	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ALB—multiple sclerosis	1.11e-05	0.000116	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MYC—multiple sclerosis	1.08e-05	0.000113	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	1.07e-05	0.000113	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.07e-05	0.000112	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	1.06e-05	0.000111	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	1.05e-05	0.00011	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL2—multiple sclerosis	1.05e-05	0.00011	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—POMC—multiple sclerosis	1.03e-05	0.000108	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MMP9—multiple sclerosis	9.9e-06	0.000104	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MYC—multiple sclerosis	9.82e-06	0.000103	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	9.8e-06	0.000103	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	9.61e-06	0.000101	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ALB—multiple sclerosis	9.37e-06	9.84e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—STAT3—multiple sclerosis	8.8e-06	9.24e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MYC—multiple sclerosis	8.18e-06	8.59e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TGFB1—multiple sclerosis	8.16e-06	8.57e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6—multiple sclerosis	8.09e-06	8.49e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MAPK1—multiple sclerosis	8e-06	8.4e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6—multiple sclerosis	7.38e-06	7.75e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOE—multiple sclerosis	6.42e-06	6.74e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6—multiple sclerosis	6.15e-06	6.46e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—POMC—multiple sclerosis	5.52e-06	5.79e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALB—multiple sclerosis	5.03e-06	5.28e-05	CbGpPWpGaD
